Skip to content
healthcare.dev

Triamterene and Hydrochlorothiazide

NDC 51655-630, Triamterene and Hydrochlorothiazide, tablet, from Northwind Health Company, LLC.

Product NDC
51655-630
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA071251
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-630 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIAMTERENE37.5 mg/1
  • HYDROCHLOROTHIAZIDE25 mg/1

Pharmacologic classes

Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
51655-630-265165506302690 TABLET in 1 BOTTLE, PLASTIC (51655-630-26)
51655-630-525165506305230 TABLET in 1 BOTTLE, DISPENSING (51655-630-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9ec3d35f-b25d-48f4-926f-f093e402ccde

Use it

Look up 51655-630 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-630 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-630. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.